The implications of "thyroid-growth-immunoglobulins" (TGI) for the understanding of sporadic nontoxic nodular goitre.
D000906:Antibodies / Q000032:analysis*; D000911:Antibodies, Monoclonal; D001681:Biological Assay; D005455:Fluorescent Antibody Technique; D006042:Goiter / Q000235:genetics / Q000276:immunology; D006044:Goiter, Nodular / Q000276:immunology*; D006111:Graves Disease / Q000235:genetics / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D018828:Immunoglobulins, Thyroid-Stimulating; D009230:Myxedema / Q000276:immunology; D011956:Receptors, Cell Surface / Q000276:immunology; D011989:Receptors, Thyrotropin; D013961:Thyroid Gland / Q000276:immunology*; D013972:Thyrotropin / Q000276:immunology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D011956:Receptors, Cell Surface; D011989:Receptors, Thyrotropin; D013972:Thyrotropin